These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 7620975)

  • 1. The biotechnology and applications of antibody engineering.
    Rapley R
    Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody engineering.
    Maynard J; Georgiou G
    Annu Rev Biomed Eng; 2000; 2():339-76. PubMed ID: 11701516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies: technologies for early discovery and engineering.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display technology: clinical applications and recent innovations.
    Azzazy HM; Highsmith WE
    Clin Biochem; 2002 Sep; 35(6):425-45. PubMed ID: 12413604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display: a powerful technology for the generation of high specificity affinity reagents from alternative immune sources.
    Finlay WJ; Bloom L; Cunningham O
    Methods Mol Biol; 2011; 681():87-101. PubMed ID: 20978962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and expression of scFv phage antibody from natural anti-keratin monoclonal antibody 3B4].
    Guan HH; Fu M; Li W; Xia RS; Wang G; Liu YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):470-2. PubMed ID: 15989794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage display and antibody engineering: a French overview.
    Aujame L; Sodoyer R; Teillaud JL
    Trends Biotechnol; 1997 May; 15(5):155-7. PubMed ID: 9161049
    [No Abstract]   [Full Text] [Related]  

  • 10. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Engineering.
    Lo KM; Leger O; Hock B
    Microbiol Spectr; 2014 Feb; 2(1):AID-0007-2012. PubMed ID: 26082127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody phage display: overview of a powerful technology that has quickly translated to the clinic.
    Kotlan B; Glassy MC
    Methods Mol Biol; 2009; 562():1-15. PubMed ID: 19554283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.
    Benhar I; Azriel R; Nahary L; Shaky S; Berdichevsky Y; Tamarkin A; Wels W
    J Mol Biol; 2000 Aug; 301(4):893-904. PubMed ID: 10966794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening.
    Mazor Y; Van Blarcom T; Carroll S; Georgiou G
    FEBS J; 2010 May; 277(10):2291-303. PubMed ID: 20423457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for selection of antibodies by phage display.
    Griffiths AD; Duncan AR
    Curr Opin Biotechnol; 1998 Feb; 9(1):102-8. PubMed ID: 9503596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of recombinant antibodies from antibody gene libraries.
    Hust M; Dübel S; Schirrmann T
    Methods Mol Biol; 2007; 408():243-55. PubMed ID: 18314587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant antibodies and in vitro selection technologies.
    Geyer CR; McCafferty J; Dübel S; Bradbury AR; Sidhu SS
    Methods Mol Biol; 2012; 901():11-32. PubMed ID: 22723092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant antibodies for cancer diagnosis and therapy.
    Hudson PJ; Souriau C
    Expert Opin Biol Ther; 2001 Sep; 1(5):845-55. PubMed ID: 11728219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering antibodies for therapy.
    Adair JR
    Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.